Barrington Research Reiterates Outperform Rating for DENTSPLY SIRONA (NASDAQ:XRAY)

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “outperform” rating restated by Barrington Research in a research report issued on Monday, Benzinga reports. They presently have a $38.00 price target on the medical instruments supplier’s stock. Barrington Research’s price objective points to a potential upside of 57.02% from the company’s current price.

Other research analysts have also issued research reports about the company. The Goldman Sachs Group decreased their target price on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a research report on Monday, May 6th. Robert W. Baird decreased their target price on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a research report on Friday, May 3rd. Evercore ISI decreased their target price on DENTSPLY SIRONA from $35.00 to $28.00 and set an “outperform” rating on the stock in a research report on Tuesday, June 25th. Needham & Company LLC decreased their target price on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a research report on Friday, May 3rd. Finally, StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $34.33.

DENTSPLY SIRONA Stock Performance

XRAY opened at $24.20 on Monday. DENTSPLY SIRONA has a 52-week low of $23.94 and a 52-week high of $41.65. The firm’s 50-day moving average price is $26.89 and its 200-day moving average price is $31.22. The company has a quick ratio of 0.97, a current ratio of 1.43 and a debt-to-equity ratio of 0.54. The company has a market cap of $5.02 billion, a P/E ratio of -55.00, a price-to-earnings-growth ratio of 1.10 and a beta of 1.01.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting the consensus estimate of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company had revenue of $953.00 million for the quarter, compared to the consensus estimate of $969.45 million. During the same quarter in the prior year, the company earned $0.39 EPS. DENTSPLY SIRONA’s quarterly revenue was down 2.6% on a year-over-year basis. As a group, equities analysts anticipate that DENTSPLY SIRONA will post 2.02 EPS for the current fiscal year.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 3,577 shares of the company’s stock in a transaction that occurred on Friday, May 31st. The shares were purchased at an average price of $27.95 per share, with a total value of $99,977.15. Following the completion of the acquisition, the director now directly owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.52% of the company’s stock.

Institutional Trading of DENTSPLY SIRONA

Several large investors have recently bought and sold shares of XRAY. Verity Asset Management Inc. purchased a new position in DENTSPLY SIRONA during the first quarter worth about $294,000. Teachers Retirement System of The State of Kentucky increased its stake in DENTSPLY SIRONA by 6.2% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 19,370 shares of the medical instruments supplier’s stock worth $642,000 after acquiring an additional 1,130 shares during the last quarter. Cetera Advisors LLC increased its stake in DENTSPLY SIRONA by 18.6% during the first quarter. Cetera Advisors LLC now owns 17,052 shares of the medical instruments supplier’s stock worth $566,000 after acquiring an additional 2,675 shares during the last quarter. Virtu Financial LLC acquired a new stake in DENTSPLY SIRONA during the first quarter worth about $1,027,000. Finally, Comerica Bank increased its stake in DENTSPLY SIRONA by 2.9% during the first quarter. Comerica Bank now owns 42,568 shares of the medical instruments supplier’s stock worth $1,413,000 after acquiring an additional 1,205 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.